Deprivation and prognosis in patients with pulmonary arterial hypertension: missing the effect of deprivation on a rare disease?

Competing Interests: Conflict of interest: E. Sofianopoulou has nothing to disclose. Conflict of interest: C. Church has nothing to disclose. Conflict of interest: G. Coghlan reports grants and personal fees for conference attendance from Johnson & Johnson, personal fees for lectures from GlaxoSmithKline, Bayer andMSD, outside the submitted work. Conflict of interest: L. Howard has nothing to disclose. Conflict of interest: M. Johnson reports grants and personal fees for meeting attendance, lectures and advisory board work from Actelion and MSD, outside the submitted work. Conflict of interest: D.G. Kiely has nothing to disclose. Conflict of interest: A. Lawrie reports grants from British Heart Foundation and Medical Research Council, grants, personal fees and travel support from Actelion Pharmaceuticals Ltd, grants and personal fees from GlaxoSmithKline, outside the submitted work. Conflict of interest: J. Lordan has nothing to disclose. Conflict of interest: M.R. Wilkins has nothing to disclose. Conflict of interest: S.J. Wort has nothing to disclose. Conflict of interest: N.W. Morrell has nothing to disclose. Conflict of interest: M.R. Toshner reports personal fees from GSK, grants and personal fees from J&J/Actelion, grants from Merck and Bayer, outside the submitted work.